The bromodomain inhibitor JQ1 suppresses PD-L1 gene expression in ovarian cancer cell lines that express high levels of this gene and increases the activity of cytotoxic T cells limiting tumor progression in a mouse model of ovarian cancer (Figure 1) [33]. The gene discussed is CD274; the disease is neoplasm.